European public procurement and grants data from official registers · Data as of 19 November 2026; updated daily.

Market report

Dermatological drug tenders in Czechia — market report, February 2026

Dermatological drug tenders in Czechia in February 2026: 6,960 tenders published (-13% month on month, -25% year on year), estimated at €434,751 in total, and 6,903 contracts awarded (-14% month on month, -26% year on year), worth €20,170,723 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,025), Krajská zdravotní, a.s. (809) and Fakultní nemocnice Bulovka (656); most contracts won: ViaPharma s.r.o. (176), ROCHE s.r.o. (155) and Takeda Pharmaceuticals Czech Republic s.r.o. (113). On average 1.8 bids per contract; 52% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
6,960
Contracts awarded
6,903
Contract value awarded
€20,170,723
Bids per contract
1.8
Tenders published per month
05K10KFeb 25: 9,302Feb 25: 9,302Feb 25Mar 25: 8,827Mar 25: 8,827Mar 25Apr 25: 8,045Apr 25: 8,045Apr 25May 25: 6,887May 25: 6,887May 25Jun 25: 7,049Jun 25: 7,049Jun 25Jul 25: 6,801Jul 25: 6,801Jul 25Aug 25: 5,988Aug 25: 5,988Aug 25Sep 25: 7,228Sep 25: 7,228Sep 25Oct 25: 7,175Oct 25: 7,175Oct 25Nov 25: 6,250Nov 25: 6,250Nov 25Dec 25: 6,652Dec 25: 6,652Dec 25Jan 26: 7,997Jan 26: 7,997Jan 26Feb 26: 6,960Feb 26: 6,9606,960Feb 26
Contracts awarded per month
05K10KFeb 25: 9,292Feb 25: 9,292Feb 25Mar 25: 8,846Mar 25: 8,846Mar 25Apr 25: 8,051Apr 25: 8,051Apr 25May 25: 6,901May 25: 6,901May 25Jun 25: 7,070Jun 25: 7,070Jun 25Jul 25: 6,810Jul 25: 6,810Jul 25Aug 25: 6,004Aug 25: 6,004Aug 25Sep 25: 7,251Sep 25: 7,251Sep 25Oct 25: 7,189Oct 25: 7,189Oct 25Nov 25: 6,262Nov 25: 6,262Nov 25Dec 25: 6,654Dec 25: 6,654Dec 25Jan 26: 8,003Jan 26: 8,003Jan 26Feb 26: 6,903Feb 26: 6,9036,903Feb 26

The highlighted bar is February 2026. Hover a bar for its figure; the table below has every value.

FigureFebruary 2026January 2026ChangeFebruary 2025Change
Tenders published6,9607,997-13%9,302-25%
Estimated value€434,751€214,027+103%€122,469+255%
Buyers3029+3%300%
Contracts awarded6,9038,003-14%9,292-26%
Contract value (awarded)€20,170,723€199,923+9,989%——
Winners295308-4%267+10%
Bids per contract1.81.9—1.8—
Single-bid contracts52%25%—40%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Hlavní město Praha 42
  • Středočeský kraj 34
  • Královéhradecký kraj 6

Procedures

  • not stated 6,878
  • Open procedure 49
  • Direct award 33

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Dermatological and musculoskeletal drugs

Questions and answers

How many dermatological drug tenders were published in Czechia in February 2026?
6,960 (by 30 buyers); for comparison, January 2026: 7,997, February 2025: 9,302.
Who won the most dermatological drug tenders in Czechia in February 2026?
By number of contracts: ViaPharma s.r.o. (176), ROCHE s.r.o. (155), Takeda Pharmaceuticals Czech Republic s.r.o. (113), Janssen-Cilag s.r.o. (112) and AbbVie s.r.o. (110); 295 companies won contracts in all.
Which buyers published the most dermatological drug tenders in February 2026?
Krajská nemocnice T. Bati, a. s. (2,025), Krajská zdravotní, a.s. (809), Fakultní nemocnice Bulovka (656), Fakultní nemocnice Brno (413) and Nemocnice České Budějovice, a.s. (320).
How competitive were dermatological drug tenders in Czechia in February 2026?
On average 1.8 bids per contract (25 contracts with a known number of bids); 52% of contracts had a single bid.
What were the contracts worth in February 2026?
€20,170,723 (awarded value, 6,903 contracts); median about €410,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.